Literature DB >> 23153290

Theoretical investigations toward the [4 + 2] cycloaddition of ketenes with N-benzoyldiazenes catalyzed by N-heterocyclic carbenes: mechanism and enantioselectivity.

Wenjing Zhang1, Yanyan Zhu, Donghui Wei, Yunxia Li, Mingsheng Tang.   

Abstract

Density functional theory (DFT) calculations have been performed to provide the first detailed computational study on the mechanism and enantioselectivity for the [4 + 2] cycloaddition reaction of ketenes with N-benzoyldiazenes catalyzed by N-heterocyclic carbenes (NHCs). Two possible mechanisms have been studied: first is the "ketene-first" mechanism (mechanism A), and second is the novel "diazene-first" mechanism (mechanism B). The calculated results reveal that mechanism B is more favorable than mechanism A because it is not only of lower energy barrier but also more consistent with the provided general experimental procedure (Huang, X.-L.; He, L.; Shao, P.-L.; Ye, S. Angew. Chem., Int. Ed.2009, 48, 192-195). The enantioselectivity-determining step is demonstrated to present during the first process of cycloaddition, and the main product configuration is verified to agree with the experimental ee values very well. This study should be of some worth on forecasting how different substituent groups of catalysts and/or reactants affect the enantioselectivity of products. The obtained novel mechanistic insights should be valuable for not only rational design of more efficient NHC catalysts but also understanding the general reaction mechanism of [4 + 2] cycloaddition of ketenes.

Entities:  

Year:  2012        PMID: 23153290     DOI: 10.1021/jo302044n

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

1.  Insights into the Competing Mechanisms and Origin of Enantioselectivity for N-Heterocyclic Carbene-Catalyzed Reaction of Aldehyde with Enamide.

Authors:  Yan Qiao; Xinhuan Chen; Donghui Wei; Junbiao Chang
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.